It is also interesting to note that CXCR4, another chemokine receptor, shows a higher expression in breast cancer tissue, whereas its ligand CXCL12 is downregulated in the same tissue, which is in contrast to the situation observed for CXCR2 [30]. This evidence concerns the gene CXCL12 and breast carcinoma.